Important safety information
Semaglutide may cause thyroid tumors. In studies in rodents, semaglutide caused thyroid C-cell tumors. It is not known whether it causes these tumors in people. Do not use semaglutide if you or a family member has ever had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Other serious side effects can include inflammation of the pancreas, gallbladder problems, low blood sugar, kidney problems, serious allergic reactions, increased heart rate and, in people with type 2 diabetes, changes in vision. Tell your provider about every medication you take, and if you are pregnant, breastfeeding or planning to become pregnant. Tell your provider before any surgery or procedure that uses anesthesia or sedation.
Based on the FDA prescribing information for Wegovy (semaglutide). Compounded semaglutide is not FDA approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.